First Time Loading...

West Pharmaceutical Services Inc
NYSE:WST

Watchlist Manager
West Pharmaceutical Services Inc Logo
West Pharmaceutical Services Inc
NYSE:WST
Watchlist
Price: 388.1 USD -0.54% Market Closed
Updated: Apr 24, 2024

Profitability Summary

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Past Growth

To be successful and remain in business, both growth and profitability are important and necessary. Net Income growth is often seen as a sign of a company's efficiency from an operational standpoint, but is influenced heavily by a company's goals and challenges and should therefore be assessed in conjunction with other metrics like revenue and operating income growth.

Margins

Profit margins represent what percentage of sales has turned into profits. Simply put, the percentage figure indicates how many cents of profit the company has generated for each dollar of sale.

Profit margins help investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Earnings Waterfall
West Pharmaceutical Services Inc

Revenue
2.9B USD
Cost of Revenue
-1.8B USD
Gross Profit
1.1B USD
Operating Expenses
-424.1m USD
Operating Income
705.1m USD
Other Expenses
-111.7m USD
Net Income
593.4m USD

Margins Comparison
West Pharmaceutical Services Inc Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
US
West Pharmaceutical Services Inc
NYSE:WST
28.5B USD
38%
24%
20%
US
Thermo Fisher Scientific Inc
NYSE:TMO
221.5B USD
40%
17%
14%
US
Danaher Corp
NYSE:DHR
184.9B USD
59%
22%
20%
US
IQVIA Holdings Inc
NYSE:IQV
43.3B USD
35%
14%
9%
CH
Lonza Group AG
SIX:LONN
37.7B CHF
36%
20%
10%
KR
Samsung Biologics Co Ltd
KRX:207940
56.2T KRW
49%
30%
23%
US
Agilent Technologies Inc
NYSE:A
40.1B USD
51%
19%
18%
US
Mettler-Toledo International Inc
NYSE:MTD
26.4B USD
59%
29%
21%
IE
ICON PLC
NASDAQ:ICLR
25.2B USD
30%
13%
8%
FR
Sartorius Stedim Biotech SA
PAR:DIM
19.2B EUR
43%
15%
9%
US
Illumina Inc
NASDAQ:ILMN
19.4B USD
61%
-2%
-26%
Country US
Market Cap 28.5B USD
Gross Margin
38%
Operating Margin
24%
Net Margin
20%
Country US
Market Cap 221.5B USD
Gross Margin
40%
Operating Margin
17%
Net Margin
14%
Country US
Market Cap 184.9B USD
Gross Margin
59%
Operating Margin
22%
Net Margin
20%
Country US
Market Cap 43.3B USD
Gross Margin
35%
Operating Margin
14%
Net Margin
9%
Country CH
Market Cap 37.7B CHF
Gross Margin
36%
Operating Margin
20%
Net Margin
10%
Country KR
Market Cap 56.2T KRW
Gross Margin
49%
Operating Margin
30%
Net Margin
23%
Country US
Market Cap 40.1B USD
Gross Margin
51%
Operating Margin
19%
Net Margin
18%
Country US
Market Cap 26.4B USD
Gross Margin
59%
Operating Margin
29%
Net Margin
21%
Country IE
Market Cap 25.2B USD
Gross Margin
30%
Operating Margin
13%
Net Margin
8%
Country FR
Market Cap 19.2B EUR
Gross Margin
43%
Operating Margin
15%
Net Margin
9%
Country US
Market Cap 19.4B USD
Gross Margin
61%
Operating Margin
-2%
Net Margin
-26%

Return on Capital

Return on capital ratios give a sense of how well a company is using its capital (equity, assets, capital employed, etc.) to generate profits (operating income, net income, etc.). In simple words, these ratios show how much income is generated for each dollar of capital invested.

Return on Capital Comparison
West Pharmaceutical Services Inc Competitors

Country Company Market Cap ROE ROA ROCE ROIC
US
West Pharmaceutical Services Inc
NYSE:WST
28.5B USD
21%
16%
23%
22%
US
Thermo Fisher Scientific Inc
NYSE:TMO
221.5B USD
13%
6%
9%
8%
US
Danaher Corp
NYSE:DHR
184.9B USD
9%
6%
7%
6%
US
IQVIA Holdings Inc
NYSE:IQV
43.3B USD
23%
5%
10%
9%
CH
Lonza Group AG
SIX:LONN
37.7B CHF
7%
4%
9%
8%
KR
Samsung Biologics Co Ltd
KRX:207940
56.2T KRW
9%
5%
9%
6%
US
Agilent Technologies Inc
NYSE:A
40.1B USD
21%
11%
14%
14%
US
Mettler-Toledo International Inc
NYSE:MTD
26.4B USD
-1 261%
23%
48%
28%
IE
ICON PLC
NASDAQ:ICLR
25.2B USD
7%
4%
7%
6%
FR
Sartorius Stedim Biotech SA
PAR:DIM
19.2B EUR
8%
4%
7%
5%
US
Illumina Inc
NASDAQ:ILMN
19.4B USD
-19%
-11%
-1%
-1%
Country US
Market Cap 28.5B USD
ROE
21%
ROA
16%
ROCE
23%
ROIC
22%
Country US
Market Cap 221.5B USD
ROE
13%
ROA
6%
ROCE
9%
ROIC
8%
Country US
Market Cap 184.9B USD
ROE
9%
ROA
6%
ROCE
7%
ROIC
6%
Country US
Market Cap 43.3B USD
ROE
23%
ROA
5%
ROCE
10%
ROIC
9%
Country CH
Market Cap 37.7B CHF
ROE
7%
ROA
4%
ROCE
9%
ROIC
8%
Country KR
Market Cap 56.2T KRW
ROE
9%
ROA
5%
ROCE
9%
ROIC
6%
Country US
Market Cap 40.1B USD
ROE
21%
ROA
11%
ROCE
14%
ROIC
14%
Country US
Market Cap 26.4B USD
ROE
-1 261%
ROA
23%
ROCE
48%
ROIC
28%
Country IE
Market Cap 25.2B USD
ROE
7%
ROA
4%
ROCE
7%
ROIC
6%
Country FR
Market Cap 19.2B EUR
ROE
8%
ROA
4%
ROCE
7%
ROIC
5%
Country US
Market Cap 19.4B USD
ROE
-19%
ROA
-11%
ROCE
-1%
ROIC
-1%

Free Cash Flow

Free cash flow (FCF) is the money a company has left over after paying its operating expenses and capital expenditures. The more free cash flow a company has, the more it can allocate to dividends, paying down debt, and growth opportunities.

If a company has a decreasing free cash flow, that is not necessarily bad if the company is investing in its growth.

See Also

Discover More